Effects of vitamin D3 derivative -calcitriol on pharmacological reactivity of aortic rings in a rodent PCOS model

Pharmacological Reports

Volumn 65, Issue 2, 2013, Pages 476-483

  Masszi, Gabriella ^a   Novak, Agnes ^b   Tarszabo, Robert ^c   Horvath, Eszter Maria ^b   Buday, Anna ^c   Ruisanchez, Eva ^b   Tokes, Anna Maria ^b   Sara, Levente ^b   Benko, Rita ^b   Nadasy, Gyorgy L ^b   Revesz, Csaba ^c   Hamar, Peter ^c   Benyó, Zoltán ^b   Varbiro, Szabolcs ^b  

^a BAJCSY ZSILINSZKY HOSPITAL   (Hungary)

^b SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^c Department of Pathophysiology ^*  (Hungary)

Author keywords

Aorta; Calcitriol; DHT; NO; PCOS; Vascular reactivity; Vitamin D3

Indexed keywords

ACETYLCHOLINE; AMOXICILLIN PLUS CLAVULANIC ACID; ANDROSTANOLONE; CALCITRIOL; NITRIC OXIDE SYNTHASE; NORADRENALIN; PENTOBARBITAL; PROSTANOID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; DRUG ACTIVITY; EX VIVO STUDY; FEMALE; HYPERANDROGENISM; IN VIVO STUDY; INFECTION PREVENTION; MEAN ARTERIAL PRESSURE; MORPHOLOGY; NONHUMAN; OVARY POLYCYSTIC DISEASE; POSTOPERATIVE INFECTION; RAT; VASOCONSTRICTION; VASODILATATION;

EID: 84879341622     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(13)71023-5     Document Type: Article

References (21)

1. Agarwal N, Rice SP, Bolusani H, Luzio SD, Dunseath G, Ludgate M, Rees DA: Metformin reduces arterial stiffness and improves endothelial function in young women with polycystic ovary syndrome: a randomized, placebo-controlled, crossover trial. J Clin Endocrinol Metab, 2010, 95, 722-730.
2. Arikan S, Akay H, Bahceci M, Tuzcu A, Gokalp D: The evaluation of endothelial function with flowmediated dilatation and carotid intima media thickness in young nonobese polycystic ovary syndrome patients; existence of insulin resistance alone may not represent an adequate condition for deterioration of endothelial function. Fertil Steril, 2009, 91, 450-455.
3. Buday A, Orsy P, Godó M, Mózes M, Kökény G, Lacza Z, Koller A et al.: Elevated systemic TGF-b impairs aortic vasomotor function through activation of NADPH oxidase-driven superoxide production and leads to hypertension, myocardial remodeling, and increased plaque formation in apoE-/-mice. Am J Physiol, 2010, 299, H386-H395.
4. Cussons AJ, Watts GF, Stuckey BG: Dissociation of endothelial function and arterial stiffness in nonobese women with polycystic ovary syndrome (PCOS). Clin Endocrinol, 2009, 71, 808-814.
5. Dokras A: Cardiovascular disease risk factors in polycystic ovary syndrome. Semin Reprod Med, 2008, 26, 39-44.
6. Fernandes GS, Gerardin DC, Assumpção TA, Campos KE, Damasceno DC, Pereira OC, Kempinas WD: Can vitamins C and E restore the androgen level and hypersensitivity of the vas deferens in hyperglycemic rats? Pharmacol Rep, 2011, 63, 983-991.
7. Horvath B, Orsy P, Benyó Z: Endothelial NOS-mediated relaxations of isolated thoracic aorta of the C57BL/6J mouse: a methodological study. J Cardiovasc Pharmacol, 2005, 45, 225-231.
8. Keller J, Mandala M, Casson P, Osol G: Endothelial dysfunction in a rat model of PCOS: evidence of increased vasoconstrictor prostanoid activity. Endocrinology, 2011, 152, 4927-4936.
9. Kotsa K, Yavropoulou MP, Anastasiou O, Yovos JG: Role of vitamin D treatment in glucose metabolism in polycystic ovary syndrome. Fertil Steril, 2009, 92, 1053-1058.
10. Kravariti M, Naka KK, Kalantaridou SN, Kazakos N, Katsouras CS, Makrigiannakis A, Paraskevaidis EA et al.: Predictors of endothelial dysfunction in young women with polycystic ovary syndrome. J Clin Endocrinol Metab, 2005, 90, 5088-5095.
11. Lakhani K, Constantinovici N, Purcell WM, Fernando R, Hardiman P: Internal carotid artery haemodynamics in women with polycystic ovaries. Clin Sci (Lond), 2000, 98, 661-665.
12. Mannerås L, Cajander S, Holmang A, Seleskovic Z, Lystig T, Lönn M, Stener-Victorin E: A new rat model exhibiting both ovarian and metabolic characteristics of polycystic ovary syndrome. Endocrinology, 2007, 148, 3781-3791.
13. Meyer C, McGrath BP, Teede HJ: Effects of medical therapy on insulin resistance and the cardiovascular system in polycystic ovary syndrome. Diabetes Care, 2007, 30, 471-478.
14. Naka KK, Kalantaridou SN, Kravariti M, Bechlioulis A, Kazakos N, Calis KA, Makrigiannakis A et al.: Effect of the insulin sensitizers metformin and pioglitazone on endothelial function in young women with polycystic ovary syndrome: a prospective randomized study. Fertil Steril, 2011, 95, 203-209.
15. Przybylski R, Mccune S, Hollis B, Simpson R U: Vitamin D deficiency in the spontaneously hypertensive heart failure [SHHF] prone rat. Nutr Metab Cardiovasc Dis, 2010, 20, 641-646.
16. Sara L, Antal P, Masszi G, Buday A, Horvath EM, Hamar P, Monos E, Nadasy GL, Varbiro S: Arteriolar insulin resistance in a rat model of polycystic ovary syndrome. Fertil Steril, 2012, 97, 462-468.
17. Soyman Z, Noyan V, Tulmac M, Yucel A, Sagsoz N, Bayrak T, Bayrak A, Cakir E: Serum paraoxonase 1 activity, asymmetric dimethylarginine levels, and brachial artery flow-mediated dilatation in women with polycystic ovary syndrome. Fertil Steril, 2011, 95, 1067-1072.
18. Thys-Jacobs S, Donovan D, Papadopoulos A, Sarrel P, Bilezikian JP: Vitamin D and calcium dysregulation in the polycystic ovarian syndrome. Steroids, 1999, 64, 430-435.
19. Weishaar RE, Simpson RU: Vitamin D3 and cardiovascular function in rats. J Clin Invest, 1987, 79, 1706-1712.
20. Wong MS, Delansorne R, Man RY, Svenningsen P, Vanhoutte PM: Chronic treatment with vitamin D lowers arterial blood pressure and reduces endotheliumdependent contractions in the aorta of the spontaneously hypertensive rat. Am J Physiol, 2010, 299, H1226-H1234.
21. Yanes LL, Romero DG, Moulana M, Lima R, Davis DD, Zhang H, Lockhart R et al.: Cardiovascular-renal and metabolic characterization of a rat model of polycystic ovary syndrome. Gender Med, 2011, 8, 103-115.